The Allstate Corporation logo ALL - The Allstate Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 21
HOLD 21
SELL 1
STRONG
SELL
0
| PRICE TARGET: $244.38 DETAILS
HIGH: $281.00
LOW: $215.00
MEDIAN: $239.00
CONSENSUS: $244.38
UPSIDE: 12.83%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 36.1% below fair value
Current Price $216.60
Bear Case $288.28 33.1% upside ($288.28 - $216.60) / $216.60 = 33.1% ROTCE 20.0% → 4.00x TBV
Fair Value $338.96 56.5% upside ($338.96 - $216.60) / $216.60 = 56.5% ROTCE 25.0% → 4.00x TBV
Bull Case $440.65 103.4% upside ($440.65 - $216.60) / $216.60 = 103.4% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

49.5%
6.0%

Key Value Driver

ROTCE (49.5%) vs. cost of equity (6.0%)

Implied Market Multiple 2.68x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $244.38 from 44 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $338.96 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $244.38 (from 44 analysts). Our estimate is 55% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly